Protein map of rare childhood brain tumors could reveal new drug targets
NCT ID NCT04868799
First seen Nov 20, 2025 · Last updated Jun 12, 2026 · Updated 25 times
Summary
This study looked at tumor samples from 44 children with a rare and aggressive cancer called rhabdoid tumor. Researchers used advanced protein analysis to understand differences between tumors, hoping to identify new targets for future treatments. No experimental therapy was given; the goal was to gather knowledge for better therapies down the road.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de neurochirurgie - Hôpital Necker Enfants malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.